Terms: = Head and neck cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911
170 results:
1. SGLT2 inhibition and three urological cancers: Up-to-date results.
Lin L; Ning K; Xiang L; Peng L; Li X
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3797. PubMed ID: 38523292
[TBL] [Abstract] [Full Text] [Related]
2. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid cancer Survivors in the United States.
Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
[No Abstract] [Full Text] [Related]
3. Evaluation of salivary transferrin in patients with oral squamous cell carcinoma.
Tavakoli F; Ghavimi MA; Fakhrzadeh V; Abdolzadeh D; Afshari A; Eslami H
Clin Exp Dent Res; 2024 Feb; 10(1):e809. PubMed ID: 37964689
[TBL] [Abstract] [Full Text] [Related]
4. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
[TBL] [Abstract] [Full Text] [Related]
5. Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With Thyroid cancer.
Roh YH; Chung SR; Baek JH; Choi YJ; Sung TY; Song DE; Kim TY; Lee JH
Korean J Radiol; 2023 Oct; 24(10):1028-1037. PubMed ID: 37793671
[TBL] [Abstract] [Full Text] [Related]
6. Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer.
Philips R; Alnemri A; Amin D; Patel J; Topf MC; Johnson JM; BarAd V; Axelrod R; Argiris A; Fundakowski C; Luginbuhl AJ; Cognetti DM; Curry JM
Cancer; 2024 Mar; 130(6):863-875. PubMed ID: 37788128
[TBL] [Abstract] [Full Text] [Related]
7. Hsa-miR-26a-5p improves OSCC sensitivity to ferroptosis by inhibiting SLC7A11.
Liang B; Wu Y
Arch Oral Biol; 2023 Dec; 156():105807. PubMed ID: 37776596
[TBL] [Abstract] [Full Text] [Related]
8. Peptidome-wide association analysis of Epstein-Barr virus identifies epitope repertoires associated with nasopharyngeal carcinoma.
Deng CM; Wang TM; He YQ; Zhang WL; Xue WQ; Li DH; Yang DW; Wang QL; Liao Y; Diao H; Jiang CT; Zhang JB; Yuan LL; Chen XY; Zhou T; Li XZ; Zhang PF; Zheng XH; Zhang SD; Hu YZ; Xu M; Zeng MS; Feng L; Jia WH
J Med Virol; 2023 Jun; 95(6):e28860. PubMed ID: 37310118
[TBL] [Abstract] [Full Text] [Related]
9.
Alamri AM; Alkhilaiwi FA; Khan NU; Tasleem M
Anticancer Agents Med Chem; 2023; 23(19):2111-2126. PubMed ID: 37287303
[TBL] [Abstract] [Full Text] [Related]
10. Chronic Lymphocytic Thyroiditis May Limit the Utility of Molecular Testing in AUS/FLUS Thyroid Nodules.
Remer LF; Linhares SM; Scola WH; Lew JI
J Surg Res; 2023 Sep; 289():229-233. PubMed ID: 37148856
[TBL] [Abstract] [Full Text] [Related]
11. Association between type of drinking water and upper gastrointestinal cancer incidence in the Linxian General Population.
Yang H; Wang JB; Wang XK; Fan JH; Qiao YL
BMC Cancer; 2023 May; 23(1):397. PubMed ID: 37142988
[TBL] [Abstract] [Full Text] [Related]
12. Causal effects of education attainment on oral and oropharyngeal cancer: New evidence from a meta-analysis and Mendelian randomization study.
Chen G; Xie J; Liu D; Zhang X; Tang A
Front Public Health; 2023; 11():1132035. PubMed ID: 37124787
[TBL] [Abstract] [Full Text] [Related]
13. Biomarkers predicting clinical outcomes in nasopharyngeal cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis.
Qian X; Chen H; Tao Y
Front Immunol; 2023; 14():1146898. PubMed ID: 37063822
[TBL] [Abstract] [Full Text] [Related]
14. Deconstructive versus reconstructive approach to internal carotid artery blowout in radiated nasopharyngeal carcinoma: A tertiary center experience and systematic review.
Xu X; Gopinathan A; Ong YK; Thye Thong MK; Loh WS; Loh KS
Head Neck; 2023 Jun; 45(6):1604-1614. PubMed ID: 37036797
[TBL] [Abstract] [Full Text] [Related]
15. Serum thyroglobulin testing after thyroid lobectomy in patients with 1-4 cm papillary thyroid carcinoma.
Jang A; Jin M; Kim CA; Jeon MJ; Lee YM; Sung TY; Kim TY; Kim WB; Shong YK; Kim WG
Endocrine; 2023 Aug; 81(2):290-297. PubMed ID: 36913171
[TBL] [Abstract] [Full Text] [Related]
16. Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020.
Perera ND; Bellomo TR; Schmidt WM; Litt HK; Shyu M; Stavins MA; Wang MM; Bell A; Saleki M; Wolf KI; Ionescu R; Tao JJ; Ji S; O'Keefe RM; Pun M; Takasugi JM; Steinberg JR; Go RS; Turner BE; Mahipal A
Oncologist; 2023 Jun; 28(6):510-519. PubMed ID: 36848266
[TBL] [Abstract] [Full Text] [Related]
17. Thyroid cytology: The reality before and after the introduction of ultrasound classification systems for thyroid nodules.
Lopes SC; Shah B; Eloy C
Endocrinol Diabetes Nutr (Engl Ed); 2023 Jan; 70(1):39-47. PubMed ID: 36764746
[TBL] [Abstract] [Full Text] [Related]
18. Conventional ultrasonography and elastosonography in diagnosis of malignant thyroid nodules: A systematic review and meta-analysis.
Zhang D; Wang XN; Jiang L; Yu CX; Chen YN; Yu XJ; Pan MF
Front Endocrinol (Lausanne); 2022; 13():1082881. PubMed ID: 36686488
[TBL] [Abstract] [Full Text] [Related]
19. Gingival and alveolar mucosal reactive hyperplastic lesions: a retrospective clinical and histological study of 996 cases.
Baesso RC; Azevedo RS; Picciani BL; Pires FR
Med Oral Patol Oral Cir Bucal; 2023 Jul; 28(4):e347-e354. PubMed ID: 36641745
[TBL] [Abstract] [Full Text] [Related]
20. Adjuvant chemotherapy in node-positive patients after esophagectomy for esophageal squamous cell carcinoma.
Jeon YJ; Cho JH; Choi YS; Shim YM; Sun JM; Kim HK
Thorac Cancer; 2023 Feb; 14(6):624-635. PubMed ID: 36631064
[TBL] [Abstract] [Full Text] [Related]
[Next]
